Smoking Clinical Trials 2023

Browse 100 Smoking Medical Studies Across 136 Cities

6 Phase 3 Trial · 259 Smoking Clinics

Reviewed by Michael Gill, B. Sc.
10 Smoking Clinical Trials Near Me
Top Hospitals for Smoking Clinical Trials
Image of M D Anderson Cancer Center in Texas.
M D Anderson Cancer Center
Houston
8Active Trials
0All Time Trials for Smoking
2014First Smoking Trial
Image of Brown University School of Public Health in Rhode Island.
Brown University School of Public Health
Providence
3Active Trials
0All Time Trials for Smoking
2021First Smoking Trial
Image of University of Pennsylvania in Pennsylvania.
University of Pennsylvania
Philadelphia
3Active Trials
0All Time Trials for Smoking
2021First Smoking Trial
Image of University of Texas MD Anderson Cancer Center in Texas.
University of Texas MD Anderson Cancer Center
Houston
3Active Trials
0All Time Trials for Smoking
2007First Smoking Trial
Image of Center for Alcohol and Addiction Studies in Rhode Island.
Center for Alcohol and Addiction Studies
Providence
2Active Trials
0All Time Trials for Smoking
2020First Smoking Trial
Top Cities for Smoking Clinical Trials
Image of Houston in Texas.
Houston
19Active Trials
M D Anderson Cancer CenterTop Active Site
Image of Miami in Florida.
Miami
15Active Trials
US13; LCC Medical Research Institute, LLCTop Active Site
Smoking Clinical Trials by Phase of TrialSmoking Clinical Trials by Age Group
< 65 Smoking Clinical Trials
1Active Smoking Clinical Trials
Most Recent Smoking Clinical TrialsTop Treatments for Smoking Clinical Trials
Treatment Name
Active Smoking Clinical Trials
All Time Trials for Smoking
First Recorded Smoking Trial
Nicotine Replacement
3
3
2018
Cigarette
2
2
2017
Varenicline
2
2
2015
Smoking Cessation Intervention
2
2
2017
Culturally-tailored Tobacco Treatment Intervention
1
1
2023

What Are Smoking Clinical Trials?

Smoking is one of the leading causes of death and leads to disease and disability by harming nearly every part of the body. According to the CDC, 16 million+ Americans are living with diseases caused by smoking. In comparison, secondhand smoke exposure leads to 41,000 deaths among nonsmoking adults and 400 deaths among infants yearly.

Smoking can cause lung diseases, diabetes, stroke, cancer, heart diseases, etc., and increase the risk of eye diseases, immune system problems, and tuberculosis.

Many smoking clinical trials focus on the shift from cigarette smoking to e-smoking or other variants to see their health effects.

Why Is Smoking Being Studied Through Clinical Trials?

Globally, tobacco use is universally recognized as the foremost preventable cause of cancer and is responsible for 30% of all cancer-related deaths in the United States. Moreover, the economic burden of smoking can't be ignored. Cigarette smoking cost the U.S. more than $600 billion in 2018, including more than $240 billion in healthcare spending and nearly $372 billion in lost productivity.

What Are The Types of Treatments Available For Smoking?

Study on smoking clinical trials is ongoing. A recent randomized, controlled trial studies the effect of switching from cigarette smoking to e-cigarettes. The 8-cohort parallel study assesses changes in select biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in generally healthy smokers switching to investigational study products (IPs). Subjects include smokers, non-smokers, and individuals undergoing smoking abstinence.

Other smoking clinical trials emphasize the need for smoking history and data collection for oncology clinical trials as they affect the outcomes and treatments.

What Are Some Recent Breakthrough Clinical Trials For Smoking?

There have been several landmark studies involving smoking in recent years. Some of the most recent studies are:

2023: Treatment Of Tobacco Smoking - this study concluded that the combination of medication and behavioral counseling while using nicotine replacement therapy (NRT) products was associated with a quit rate of 15.2% over 6 months compared with a quit rate of 8.6% with brief advice or usual care.

2013: Ask-Advise-Connect - there are many healthcare smoking cessation quitlines available, such as AAR programs, but rates of primary care referrals to quitlines are low, and most referred smokers fail to call for assistance. This study focuses on a new approach of Ask-Advice-Connect, where smokers who agreed to be connected, their contact number was sent electronically to the quitline daily, and patients were called proactively by the quitline within 48 hours. As a result, 7.8% of all identified smokers enrolled in treatment.

Who Are Some Of The Key Opinion Leaders / Researchers / Institutions Conducting Smoking Clinical Trial Research?

Institute for Global Tobacco Control's (IGTC)

IGTC aims to develop effective tobacco control interventions to prevent death and disease from tobacco products. IGTC has trained more than 2,000 professionals through capacity-building programs and produced more than 200 articles in peer-reviewed academic journals.

Bartoz Koszowski, PhD

Bartoz Koszowski has done his Pharm.D. (2007) and Ph.D. in Toxicology and Pharmacology (2011) from the Medical University of Silesia, Poland. His current research is focused on the use of tobacco products and various factors that influence user behaviors.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: September 13th, 2023

References1 Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119-27. https://pubmed.ncbi.nlm.nih.gov/19328832 Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119-27. doi: 10.1111/j.1360-0443.1991.tb01879.x. https://pubmed.ncbi.nlm.nih.gov/19328833 Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32. doi: 10.1146/annurev.clinpsy.3.022806.091415. https://pubmed.ncbi.nlm.nih.gov/185099024 Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan;32(1):193-203. doi: 10.2337/dc08-9025. Epub 2008 Oct 22. https://pubmed.ncbi.nlm.nih.gov/189459205 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008 Sep;53(9):1217-22. https://pubmed.ncbi.nlm.nih.gov/188072746 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008 Sep;53(9):1217-22. No abstract available. https://pubmed.ncbi.nlm.nih.gov/188072747 Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32. Review. https://pubmed.ncbi.nlm.nih.gov/185099028 National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK179276/ https://pubmed.ncbi.nlm.nih.gov/244557889 National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014. https://pubmed.ncbi.nlm.nih.gov/2445578810 Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996 Nov-Dec;11(2):87-98. Review. https://pubmed.ncbi.nlm.nih.gov/10163601